#Curative covid test edinburg tx manual

Sensible's design is simple: fewer parts and fewer process steps, which means fewer mistakes and safer, more affordable results. The Sensible Diagnostics Platform was built based on over two years of experience performing over 2 million molecular point-of-care tests in the field while part of Curative’s initial diagnostic focus. Despite this, PCR has yet to supplant the lateral flow immunoassay as the go-to, point-of-care testing technology because of its high costs and relative operational complexity.

#Curative covid test edinburg tx manual

While it offers a relatively inexpensive result in a compact package, it is common knowledge that this technology is inaccurate and is prone to user errors due to its manual workflow.

Since the ‘80s, lateral flow immunoassay technology has dominated the infectious disease testing market. “This device is truly a game changer for diagnostics testing in retail clinics, urgent care, and beyond, and will provide fast, accurate, and affordable results.” “We are excited to be rolling out Sensible Diagnostics to bring a revolutionary, efficient PCR 10-minute desktop testing platform to the masses,” said Fred Turner, CEO and co-founder of Curative.

With a 10-minute time-to-result, market-leading test pricing, and lab-quality PCR results, the Sensible Platform is poised to change the current standard of care. The new Sensible PCR Platform (which was designed to support Curative’s legacy next-generation testing operations) combines speed, affordability, and accuracy, making it an easy drop-in upgrade for current point-of-care testing workflows. LOS ANGELES-( BUSINESS WIRE)-Curative Inc., a leading health services company that recently launched a new health plan out of Texas, announces the spin-off of Sensible Diagnostics, whose aim is to commercialize their groundbreaking point-of-care PCR testing platform.